Member Info for Pharmhall

TKO has commenced commercial copper production at its second copper mine in US, with first sales possible at very end of year. Meanwhile, strong 3Q production of copper (+39%) and molybdenum (+211%) over 2Q from its existing Gibraltar mine, with the Cu being sold at peak prices. Upped its 2025 production expectations. All augurs well for strong results for 2025. One to watch.

JL...I pretty much agree with all your thoughts. My only addition would be that: I think its independence will be challenged very shortly after all the non-core disposals are made. My experience with corporate activity suggests that a buyer would far rather pay up a bit more for a cleaned up business (i.e. pure defence) rather than taking the whole lot and then having to find buyers for the non-core divisions. Takes too much of their time and might not get much for them anyway. I continue top watch this space.

JL....Good to see MSI hitting 1500p for the first time. Fingers crossed for good news and a good run into the Dec interims.

RM...Given its 12-month trading history, I have taken advantage of the recent drift back to 40.5p to dip my toes in the water on your MWE recommendation. Its trading on 10.5x 2025 P/E and at offers a 6.2% yield (Allenby forecasts). Sounds good to me.

Far more important for performance will be the 4Q production report on 10 Oct.

RM...I rarely sell out on bad news and the shares have tumbled...I always feel that I missed the boat. In a couple of months, I will take another look at the fundamentals and broker forecasts and then reassess. At that point if I think that I made an investment error and the company is no good, I do sell them; if I feel that the fundamentals are good and that it will recover over time, then I will often look for an opportunity over the next six month to (at least) double up on my holding.

Thanks for reminder. I'll post my forecasts...but will do it nearer the release date.

I must admit that I used the news and bounce this morning to sell 1k shares, still leave me with 8K in ISA and 3k in SIPP.

On separate note, I also wanted to say that you cannot get everything right and took a big hit with Billington (BILN) yesterday. Thankfully, I have not got too many failures in portfolio.

Given your post yesterday JL, today's RNS made me smile!

THX...yes it's already on watchlist. Missed last week's excitement.

I'm not averse to locking in some profits, but need to have some good ideas about where to reinvest the cash. I'm exposed to property myself, so don't buy property shares; and construction/housebuilders is all on debt, so I don't go there either. I hate retail, as I know how much less my family is spending, but I do consider the supermarkets occasionally. My list of stocks ignores the Tech stocks, which are all US based and do not pay dividends.

aviva (av.), m&g (mng), rtz (rio), glencore (glen), ithaca (ith), hsbc, barclays (barc), bab**** (bab), jackson (us:jkx)

Great minds...I did exactly the same , for the same reasons.

RM...I agree you need to be incredibly cautious of small healthcare at the moment...several are desperately short of working capital and dilutive fund raises are inevitable. For example, on the back of a potentially lucrative US deal, Renalytix (RENX) raised some new capital last week. The day after the Placing, it announced sales forecasts for the next two years and the new contract is making almost no difference. I wonder why this information was not included in the Placing material? Also, three well-paid (combined income from a few companies) directors put up £10k each (wow!) and the CEO did not participate at all......tells me everything that I need to know.

Wow...that's a blast from the past!

I (and both my children) have owned ELIX for about 2 years (bought @506p). The more I learn about this consultancy company, the better it gets. I have just come off the 1H'25 presentation on Investor Meet today and it is really worth listening to (CEO goes on a bit, but look beyond that, he's excited!). Its a £400m mkt cap company and is aiming to be in the FTSE250 by this time next year. To do that it needs to have a mkt cap of ca.£550m. It has really good underlying (16-19%) growth, cross-selling opportunities, and acquisitions (+5-10% on growth) are made with cash to prevent dilution. Has just made a cracking acquisition to give it more US exposure and add cross-selling opportunities. All the partners and many staff are shareholders. If previous experience repeats itself, the shares tend to drift back between results announcements but with it now being on the main market and institutions likely to be after it, I cannot say if that happens again over the next couple of months. ELIX is definitely one to tuck away for long-term 20% p.a. growth and inclusion in the FTSE indices that forces institutions to buy the shares.

https://www.investormeetcompany.com/meetings/interim-results-499

JL, RM...First, I'll admit that I (and both my children) am a shareholder about 2 years @506p. I have just come off the 1H'25 presentation on Investor Meet today and it is really worth listening to (CEO goes on a bit, but look beyond that, he's excited!). Its a £400m mkt cap company and is aiming to be in the FTSE250 by this time next year. To do that it needs to have a mkt cap of ca.£550m. It has really good underlying (16-19%) growth, cross-selling opportunities, and acquisitions (+5-10% on growth) are made with cash to prevent dilution. All the partners and many staff are shareholders. If previous experience repeats itself, the shares tend to drift back between results announcements but with it now being on the main market and institutions likely to be after it, I cannot say if that happens again over the next few months. But definitely one to tuck away for long-term 20% p.a. growth.

https://www.investormeetcompany.com/meetings/interim-results-499

Sympathies...best of luck. Let's continue to search out some more good ones.

JL, RM...I appreciate that microcaps (higher risk) are not for everyone, but I like a blend between safe plays (defence, miners, banks, insurance) and some potential multi-baggers. To that end the hot share of the day is Light Science Technologies (LST). This company is responsible for Injectaclad which is a method of retrofitting fire safety into large buildings without the need to remove the cladding. It is worth reading back through the recent trading RNSs released by the company. I think that it has had a push by Investors Chronicle and a recent seller has declared he is now completely out of the stock. I have my usual small cap slug.

JL...this has been one of my core holdings for several years. I've done very well on it....very happy!

Many a true work spoken in jest....I actually DO have WB's telephone number!! When we eventually meet up, I will explain how.